Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Product name | Adenosine Triphosphate Disodium | Manufacture date | Jan.12.2025 |
Batch number | SW250112 | Analysis date | Jan.13.2025 |
Batch quantity | 500kg | Expiry date | Jan.12.2027 |
Item | Specification | Result |
Appearance | White fine Powder | Complies |
Particle Size | 100% pass 80 mesh | Complies |
Assay | 99% | 99.12% |
Oder | Characteristic | Complies |
Taste | Characteristic | Complies |
Loss on Drying | ≤5.0% | 2.20% |
Residue on Ignition | ≤0.1% | 0.05% |
Residual | ≤0.1% | Complies |
Residual Ethanol | ≤0.5% | Complies |
Heave Mentals | ≤10ppm | Complies |
Na | ≤0.1% | <0.1% |
Pb | ≤3 ppm | Complies |
Total Plate | <1000CFU/g | Complies |
Yeast & Mold | <100 CFU /g | Complies |
E. Coli | Negative | Complies |
Salmonella | Negative | Complies |
Conclusion | Meet the requirement |
Packing description: | Sealed export grade drum & double of sealed plastic bag |
Storage: | Store in cool & dry place. keep away from strong light and heat |
Shelf life: | 2 years when properly stored |
Adenosine triphosphate is used as Pharmaceutical Raw Material.
Adenosine triphosphate can be used in the disease caused by tissue injury and activity reduction of ecto enzyme , including heart failure, carditis, miocardial infarction, cerebral arteriosclersis, coronary sclerosis, progressive muscular atrophy , cerebral hemorrhage , chronic hepatitis, cirrhosis of liver and hearing handicap, etc.
Similiar product recommendation | |||
AMP | AMP-NA2 | ADP-NA2 | CMP |
CDP | GMP | UMP | UDP |
IDP | Poly I | Poly C | PIC |
CMP-NA2 | UTP | CAMP | DB-CAMP |